Subscribe and Stay Informed
Receive industry-leading content from our experts
Start exploring
Q&A with Advarra’s Manager of Ongoing Review MaryJo Carter
https://advarra.wistia.com/medias/nbwuqrazu4 MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping…
Sponsor’s Guide to IRB Approval (Part V): How to Speed Up IRB Approvals
Institutional review board (IRB) approval is a critical milestone in clinical research, but it can…
Data Safety Monitoring Boards (DSMBs) in the Era of AI and Adaptive Clinical Trials
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are…
Why Should Local IRBs and HRPPs Collaborate with External IRBs?
Multisite research and clinical trials increasingly rely on a single IRB (sIRB) for review. This increase reflects federal mandates, sponsor expectations,…
Sponsor’s Guide to IRB Approval (Part IV): Preparing IRB Documents That Prevent Delays
A strong protocol and well-drafted consent form are essential, but they are not enough on…
Q&A with Advarra’s Associate Director of Client Success Evan Sander
https://advarra.wistia.com/medias/ji1t9feek6 Evan Sander knows firsthand that clinical research is never just about processes or paperwork—it’s…